Calidi Biotherapeutics (CLDI) EBIT (QoQ) (2022 - 2025)
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) EBIT (QoQ) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Calidi Biotherapeutics | 1.85 Mn | -2.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.53% |
| Sep 30, 2025 | 10.88% |
| Jun 30, 2025 | -11.89% |
| Mar 31, 2025 | -25.73% |
| Dec 31, 2024 | 22.96% |
| Sep 30, 2024 | 9.46% |
| Jun 30, 2024 | 14.51% |
| Mar 31, 2024 | 31.24% |
| Dec 31, 2023 | -35.99% |
| Sep 30, 2023 | -10.46% |
| Jun 30, 2023 | -20.74% |
| Mar 31, 2023 | -15.49% |
| Dec 31, 2022 | 32.89% |
| Sep 30, 2022 | -1,831.85% |
| Jun 30, 2022 | 31.62% |